β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects

Metabolism: Clinical and Experimental

Volumn 45, Issue 4, 1996, Pages 486-491

  Kautzky Willer, Alexandra ^b   Thomaseth, Karl ^b   Clodi, Martin ^b   Ludvik, Bernhard ^b   Waldhäusl, Werner ^b   Prager, Rudolf ^b   Pacini, Giovanni ^a  

^a Istituto di Ingeneria Biomedica del CNR   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; INSULIN;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0029926322     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90224-3     Document Type: Article

References (38)

1. Ahn KJ, Kim YS, Lee HC, et al: Clinical characteristics and possible risk factors in postrenal transplant diabetes mellitus. Transplant Proc 24:1581-1582, 1992
2. Boyle PJ: Cushing's disease, glucocorticoid excess, glucocorticoid deficiency, and diabetes. Diabetes Rev 1:301-308, 1993
3. Isoniemi HM, Ahonen J, Tikkanen MJ, et al: Long term consequences of different immunosuppressive regimens for renal allografts. Transplantation 55:494-499, 1993
4. Rizza RA, Mandarino LJ, Gerich JE: Cortisol induced insulin resistance in man: Impaired suppression of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54:131-138, 1982
5. Andersson A: Synthesis of DNA in isolated pancreatic islets maintained in tissue culture. Endocrinology 96:1051-1054, 1975
6. Billaudel B, Mathias PCF, Sutter BCJ, et al: Inhibition by corticosterone of calcium inflow and insulin release in rat pancreatic islets. J Endocrinol 100:227-233, 1984
7. Chick WL: Beta cell replication in pancreatic monolayer cultures. Effects of glucose, tolbutamide, glucocorticoid, growth hormone and glucagon. Diabetes 22:687-693, 1973
8. Hellerström C: Growth pattern of pancreatic islets in animals, in Volk BW, Wellman KF (eds): The Diabetic Pancreas. New York, NY, Plenum, 1977, pp 61-97
9. Swenne I: Pancreatic beta cell growth and diabetes. Diabetologia 35:193-201, 1992
10. Ludvik B, Clodi M, Kautzky Willer A, et al: Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia 36:84-87, 1993
11. Kautzky-Willer A, Thomaseth K, Pacini G, et al: Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 37:188-194, 1994
12. Cobelli C, Pacini G: Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes 37:223-231, 1988
13. Hartter E, Svoboda T, Ludvik B, et al: Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34:52-54, 1991
14. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest 68:1456-1467, 1981
15. Pacini G, Thomaseth K, Kautzky-Willer A, et al: An integrated mathematical model of islet amyloid polypeptide dynamics, in Patterson BW (ed): Modeling and Control in Biomedical Systems. Madison, WI, Omnipress, 1994, pp 377-378
16. Pacini G, Cobelli C: Estimation of beta cell secretion and insulin hepatic extraction by the minimal modelling technique. Comput Methods Progr Biomed 32:241-248, 1990
17. Thomaseth K: PANSYM: A symbolic equation generator for mathematical modelling, analysis and control of metabolic and pharmacokinetic systems. Comput Methods Progr Biomed 42:99-112, 1994
18. Beard JC, Halter JB, Best JD, et al: Dexamethasone-induced insulin resistance enhances beta cell responsiveness to glucose level in normal men. Am J Physiol 247:E592-E596, 1984
19. Ogawa A, Johnson JH, Onheda M, et al: Roles of insulin resistance and beta cell dysfunction in dexamethasone-induced diabetes. J Clin Invest 90:497-504, 1992
20. Wajngot A, Giacca A, Grill V, et al: The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc Natl Acad Sci USA 89:6035-6039, 1992
21. Kalhan SC, Adam PAJ: Inhibitory effect of prednisone on insulin secretion in man: Model for duplication of blood glucose concentration. J Clin Endocrinol Metab 41:600-610, 1975
22. Longano CA, Fletcher HP: Insulin release after acute hydrocortisone treatment in mice. Metabolism 32:603-608, 1983
23. Shamoon H, Soman V, Sherwin RS: The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans. J Clin Endocrinol Metab 50:495-501, 1980
24. Kitabchi AE, Jones GM, Duckworth WC: Effect of hydrocortisone and corticotropin on glucose induced insulin and proinsulin secretion in man. J Clin Endocrinol Metab 37:79-84, 1973
25. Caro JF, Amatruda JM: Glucocorticoid-induced insulin resistance. The importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes. J Clin Invest 69:866-875, 1982
26. Perley M, Kipnis DM: Effect of glucocorticoids on plasma insulin. N Engl J Med 274:1237-1241, 1966
27. Pacini G: Mathematical models of insulin secretion in physiological and clinical investigations. Comput Methods Progr Biomed 41:269-285, 1994
28. Welch S, Gebhart SSP, Bergman RN, et al: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
29. Bergman RN, Prager R, Vølund A, et al: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
30. Kahn SE, Horber FF, Prigeon RL, et al: Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes 42:1082-1085, 1993
31. Waldhäusl WK, Gasic S, Bratusch-Marrain P, et al: Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans. Diabetes 36:127-135, 1987
32. Chap Z, Jones RH, Chou J, et al: Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. J Clin Invest 78:1355-1361, 1986
33. Kraus-Friedmann N: Hormonal regulation of hepatic gluconeogenesis. Physiol Rev 64:170-259, 1984
34. Uete T, Tsuchikura H: Autoregulatory system of insulin degradation in liver. J Biochem 72:157-163, 1972
35. Kautzky-Willer A, Pacini G, Niederle B, et al: Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (oxf) 37:147-155, 1992
36. Kautzky-Willer A, Pacini G, Weissel M, et al: Elevated hepatic insulin extraction in essential hypertension. Hypertension 21:646-653, 1993
37. Bretherton-Watt D, Ghatei MA, Bloom SR, et al: Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 32:881-883, 1989
38. O'Brian TD, Westermark P, Johnson KH: Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 40:1701-1706, 1991